These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15793105)

  • 1. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax?
    Athamna A; Athamna M; Nura A; Shlyakov E; Bast DJ; Farrell D; Rubinstein E
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1323-5. PubMed ID: 15793105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.
    Athamna A; Massalha M; Athamna M; Nura A; Medlej B; Ofek I; Bast D; Rubinstein E
    J Antimicrob Chemother; 2004 Feb; 53(2):247-51. PubMed ID: 14688054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Bacillus anthracis isolates resistant to antibiotics.
    Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
    Esposito S; Gupta A; Thadepalli H
    Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
    Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary.
    Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M
    Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania.
    Caplan DM; Ivana S; Caplan ME
    Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.
    Sueke H; Kaye SB; Neal T; Hall A; Tuft S; Parry CM
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4151-5. PubMed ID: 20335613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.
    Head BM; Alfa M; Sitar DS; Rubinstein E; Meyers AF
    J Antimicrob Chemother; 2017 Feb; 72(2):417-420. PubMed ID: 27798209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):297-9. PubMed ID: 12865385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the combination of clindamycin with beta-lactam antibiotics and aminoglycosides (author's transl)].
    Adam D; Nawrath I
    Arzneimittelforschung; 1981; 31(8):1295-8. PubMed ID: 7197536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of nine South African medicinal plants in controlling Bacillus anthracis Sterne vaccine strain.
    Elisha IL; Dzoyem JP; Botha FS; Eloff JN
    BMC Complement Altern Med; 2016 Jan; 16():5. PubMed ID: 26742484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.